... (PET) radiopharmaceuticals, today announced that multiple presentations featuring POSLUMA® (flotufolastat F 18) will be presented at the upcoming ASCO 2026 Genitourinary Cancers Symposium (ASCO GU).
19, 2025 (GLOBE NEWSWIRE) -- The "GenitourinaryCollaboration and Licensing Deals 2016-2025" has been added to ResearchAndMarkets.com's offering. Fully revised and updated, the report provides details of 290 genitourinary deals from 2016 to 2025.